Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527
Condition: Healthy Volunteer Study Interventions: Drug: Period 1: AT-527 550 mg; Drug: Period 2: carbamazepine; Drug: Period 3: AT-527 550 mg + carbamazepine; Drug: Period 3: AT-527 1100 mg + carbamazepine Sponsors: Atea Pharmaceuticals, Inc.; Hoffmann-La Roche Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials